Legend Biotech Corporation
Legend Biotech Corporation (NASDAQ: LEGN) is trading at $18.97, about ₹1,821 at today's USD/INR rate, as of 25 Sep 2026, 11:54 AM ET, down 0.50% today. Indian residents can buy Legend Biotech from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$18.85
Today's high
$19.69
52 week low
$16.24
52 week high
$37.50
LEGN opened at $19.49, closed previously at $19.06, and has traded between $16.24 and $37.50 over the past 52 weeks.
About
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. Legend Biotech Corporation was founded in 2014 and is headquartered in Somerset, New Jersey.
Key statistics
Avg. volume
2.53M
Market cap
$3.51B
P/E Ratio
-37.93
Price-to-sales ratio
2.76
Enterprise value
$3.11B
Free cash flow yield
-7.29%
Debt-to-equity ratio
0.23
Return on equity
-8.70%
ROIC
-3.71%
Beta
0.40
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$1.03B
Earnings per share
-$1.60
Free cash flow
-$168.04M
Net profit margin
-7.21%
Gross margin
56.58%
EBITDA
-$232.30M
Revenue growth
64.04%
Similar securities
This is not an investment recommendation
How to buy Legend Biotech from India
Indian residents can buy Legend Biotech shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Legend Biotech and place an order
Find Legend Biotech by name or by its ticker, LEGN, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Legend Biotech trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Legend Biotech position in USD and INR. Legend Biotech pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Legend Biotech from India
Trading and taxes when buying Legend Biotech from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneLegend Biotech does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Legend Biotech stock?
Yes. Legend Biotech (LEGN) has been listed on NASDAQ since 2020, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Legend Biotech share cost in rupees?
One Legend Biotech share is $18.97 — about ₹1,821 at a USD/INR rate of 96.02 on 24 Sep 2026. Both the Legend Biotech price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Legend Biotech from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Legend Biotech?
Yes. One Legend Biotech share is $18.97, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Legend Biotech.
How are gains on Legend Biotech shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Legend Biotech price. Paasa issues a capital-gains statement for your return.
Does Legend Biotech pay a dividend?
No. Legend Biotech does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Legend Biotech from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Legend Biotech shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Legend Biotech shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Legend Biotech holding, its cost and its closing value.
How do I sell Legend Biotech and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.